Bone Financial Statements From 2010 to 2025

BBLGW Stock  USD 77.99  10.66  15.83%   
Bone Biologics financial statements provide useful quarterly and yearly information to potential Bone Biologics Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bone Biologics financial statements helps investors assess Bone Biologics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bone Biologics' valuation are summarized below:
Earnings Share
(0.14)
There are over one hundred thirteen available fundamental signals for Bone Biologics Corp, which can be analyzed over time and compared to other ratios. All traders should should validate Bone Biologics' prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable.
Check Bone Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bone Biologics' main balance sheet or income statement drivers, such as Other Operating Expenses of 11.4 M, Ebitda of 453.2 K or Total Operating Expenses of 11.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.39. Bone financial statements analysis is a perfect complement when working with Bone Biologics Valuation or Volatility modules.
  
Check out the analysis of Bone Biologics Correlation against competitors.

Bone Biologics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding225 K236.8 KM
Slightly volatile
Total Current Liabilities908.3 K956.1 K2.5 M
Pretty Stable
Other Stockholder Equity101.2 M96.4 M44.9 M
Slightly volatile
Total Liabilities908.3 K956.1 K4.7 M
Very volatile
Common Stock45748115.8 K
Very volatile
Short and Long Term Debt Total8.3 M13.5 M7.4 M
Slightly volatile
Other Current Assets858.8 K817.9 K357 K
Slightly volatile
Accounts Payable435.5 K414.8 K198.4 K
Slightly volatile
Net Receivables345.3 K378.2 K340.7 K
Slightly volatile
Current Deferred Revenue602.3 K901.2 K469.8 K
Slightly volatile
Long Term Debt10.8 M13 M9.8 M
Slightly volatile
Short and Long Term Debt11.4 M13.5 M10.3 M
Slightly volatile
Capital Stock45748120.4 K
Slightly volatile

Bone Biologics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses11.4 M10.8 M4.9 M
Slightly volatile
Depreciation And Amortization11.4 M10.8 MM
Slightly volatile
Selling General AdministrativeM2.3 M2.1 M
Pretty Stable
Research Development8.3 M7.9 M2.7 M
Slightly volatile
Interest Expense1.5 MM1.8 M
Very volatile
Tax Provision2.1 K3.7 KK
Slightly volatile
Selling And Marketing ExpensesM2.3 M2.5 M
Slightly volatile

Bone Biologics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow9.1 M8.7 M2.4 M
Slightly volatile
Other Cashflows From Financing Activities5.5 K5.8 K1.6 M
Pretty Stable
Total Cash From Financing Activities6.1 M5.8 M3.4 M
Slightly volatile
End Period Cash Flow1.8 M3.5 M1.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables111.8 K117.7 K203.3 K
Slightly volatile
Capex To Depreciation0.120.1313.3617
Slightly volatile
Inventory Turnover0.710.80.875
Slightly volatile
Days Of Inventory On Hand327368401
Slightly volatile
Payables Turnover0.00130.00132.2924
Slightly volatile
Average Inventory393.5 K442.7 K482.7 K
Slightly volatile
Days Payables Outstanding233 K281.7 K219.6 K
Slightly volatile
Income Quality0.70.960.8287
Pretty Stable
Current Ratio5.664.059.7125
Slightly volatile
Graham Number100106457
Slightly volatile
Interest Debt Per Share20.4621.53172
Slightly volatile
Debt To Assets347330168
Slightly volatile
Operating Cycle327368401
Slightly volatile
Days Of Payables Outstanding233 K281.7 K219.6 K
Slightly volatile
Ebt Per Ebit1.631.091.4736
Pretty Stable
Quick Ratio5.664.059.695
Slightly volatile
Cash Ratio5.53.289.4967
Slightly volatile
Days Of Inventory Outstanding327368401
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0171
Slightly volatile
Debt Ratio347330168
Slightly volatile

Bone Biologics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap951.5 K1.1 M1.2 M
Slightly volatile

Bone Fundamental Market Drivers

Cash And Short Term InvestmentsM

About Bone Biologics Financial Statements

Bone Biologics investors use historical fundamental indicators, such as Bone Biologics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bone Biologics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue901.2 K602.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bone Stock Analysis

When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.